Wegovy Pill Wins FDA Approval as First GLP-1 Oral Treatment for Obesity and Weight Loss
The U.S. Food and Drug Administration (FDA) has approved the first GLP-1 pill to reduce excess body weight, introducing a needle-free way to get the same active ingredient in the injectable GLP-1 drugs Ozempic and Wegovy. [1] The once-daily Wegovy pill (semaglutide) was approved for weight loss and weight maintenance in adults who are overweight … Read more